Daiyuan Shentu

State Key Laboratory Of Oncogenes And Related Genes, P.R. China
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A novel defined cuproptosis-related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer.

A novel defined cuproptosis-related signature score to predict prognosis and immunotherapy efficacy in pancreatic cancer.

Journal: Oncology letters

Published: May 15, 2025

CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment.

CREB3L1 facilitates pancreatic tumor progression and reprograms intratumoral tumor-associated macrophages to shape an immunotherapy-resistance microenvironment.

Journal: Journal for immunotherapy of cancer

Published: December 12, 2024

Targeted therapies and immunotherapies for unresectable cholangiocarcinoma.

Targeted therapies and immunotherapies for unresectable cholangiocarcinoma.

Journal: Chinese medical journal

Published: October 16, 2024

Correction to: The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.

Correction to: The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: July 05, 2024

The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.

The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: November 28, 2023

The Role of Bile Acids in Pancreatic Cancer.

The Role of Bile Acids in Pancreatic Cancer.

Journal: Current cancer drug targets

Published: September 07, 2023

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells.

PLA2G2A+ cancer-associated fibroblasts mediate pancreatic cancer immune escape via impeding antitumor immune response of CD8+ cytotoxic T cells.

Journal: Cancer letters

Published: December 05, 2022

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer.

Journal: Cancer letters

Published: November 23, 2022

Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.

Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients.

Journal: IET systems biology

Published: November 10, 2022

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer.

Journal: International journal of molecular sciences

Published: October 27, 2022

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer.

Journal: Frontiers in cell and developmental biology

Published: July 23, 2022

Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.

Prediction of Survival and Tumor Microenvironment Infiltration Based on Pyroptosis-Related lncRNAs in Pancreatic Cancer.

Journal: Disease markers

Published: July 10, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026